(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide

C24H40N4O2+2 — CID 11943835

IUPAC(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide
SMILESCCc1ccccc1NC(=O)C[NH+]1CC[NH+]([C@H](C)C(=O)N[C@@H]2CCCC[C@@H]2C)CC1
InChIInChI=1S/C24H38N4O2/c1-4-20-10-6-8-12-22(20)25-23(29)17-27-13-15-28(16-14-27)19(3)24(30)26-21-11-7-5-9-18(21)2/h6,8,10,12,18-19,21H,4-5,7,9,11,13-17H2,1-3H3,(H,25,29)(H,26,30)/p+2/t18-,19+,21+/m0/s1
InChIKeyNIJRKTVFUQBWFM-QKNQBKEWSA-P
MW416.61 g/mol
LogP0.05
Rot. Bonds7

About (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide

(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide (PubChem CID 11943835) has the molecular formula C24H40N4O2+2 and a molecular weight of 416.61 g/mol. Its IUPAC name is (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide.

Molecular Properties

Compound Name(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide
PubChem CID11943835
Molecular FormulaC24H40N4O2+2
Molecular Weight416.61 g/mol
Exact Mass416.31
IUPAC Name(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide
SMILESCCc1ccccc1NC(=O)C[NH+]1CC[NH+]([C@H](C)C(=O)N[C@@H]2CCCC[C@@H]2C)CC1
InChIInChI=1S/C24H38N4O2/c1-4-20-10-6-8-12-22(20)25-23(29)17-27-13-15-28(16-14-27)19(3)24(30)26-21-11-7-5-9-18(21)2/h6,8,10,12,18-19,21H,4-5,7,9,11,13-17H2,1-3H3,(H,25,29)(H,26,30)/p+2/t18-,19+,21+/m0/s1
InChIKeyNIJRKTVFUQBWFM-QKNQBKEWSA-P
XLogP0.05
TPSA67.08 Ų
H-Bond Donors4
H-Bond Acceptors2
Rotatable Bonds7
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500416.61
LogP ≤ 50.05
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 102

Analyze (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide?
The IUPAC name of (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide (CID 11943835) is (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide.
What is the SMILES notation for (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide?
The canonical SMILES for (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide is CCc1ccccc1NC(=O)C[NH+]1CC[NH+]([C@H](C)C(=O)N[C@@H]2CCCC[C@@H]2C)CC1.
What is the InChIKey of (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide?
The InChIKey is NIJRKTVFUQBWFM-QKNQBKEWSA-P. The full InChI is InChI=1S/C24H38N4O2/c1-4-20-10-6-8-12-22(20)25-23(29)17-27-13-15-28(16-14-27)19(3)24(30)26-21-11-7-5-9-18(21)2/h6,8,10,12,18-19,21H,4-5,7,9,11,13-17H2,1-3H3,(H,25,29)(H,26,30)/p+2/t18-,19+,21+/m0/s1.
What are the key properties of (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide?
(2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide has a molecular weight of 416.61 g/mol, XLogP of 0.05, 7 rotatable bonds, 4 hydrogen bond donors, and 2 hydrogen bond acceptors.
Where does this data come from?
All data for (2R)-2-[4-[2-(2-ethylanilino)-2-oxoethyl]piperazine-1,4-diium-1-yl]-N-[(1R,2S)-2-methylcyclohexyl]propanamide is sourced from PubChem (CID 11943835), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).